It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Single-cell RNA-sequencing (scRNA-Seq) is a compelling approach to directly and simultaneously measure cellular composition and state, which can otherwise only be estimated by applying deconvolution methods to bulk RNA-Seq estimates. However, it has not yet become a widely used tool in population-scale analyses, due to its prohibitively high cost. Here we show that given the same budget, the statistical power of cell-type-specific expression quantitative trait loci (eQTL) mapping can be increased through low-coverage per-cell sequencing of more samples rather than high-coverage sequencing of fewer samples. We use simulations starting from one of the largest available real single-cell RNA-Seq data from 120 individuals to also show that multiple experimental designs with different numbers of samples, cells per sample and reads per cell could have similar statistical power, and choosing an appropriate design can yield large cost savings especially when multiplexed workflows are considered. Finally, we provide a practical approach on selecting cost-effective designs for maximizing cell-type-specific eQTL power which is available in the form of a web tool.
Single cell RNA-sequencing can be a powerful approach to characterizing cell composition in a population of cells but is thought to be too expensive for population-scale analyses. Here, the authors show how lower coverage of more samples can increase the power to detect cell-type-specific eQTL.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University of California Los Angeles, Department of Computer Science, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
2 Bioinformatics Interdepartmental Program, University of California Los Angeles, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
3 David Geffen School of Medicine, University of California Los Angeles, Department of Pathology and Laboratory Medicine, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
4 University of California San Francisco, Institute for Human Genetics, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811); University of California San Francisco, Bakar Computational Health Sciences Institute, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811); Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811)
5 University of California San Francisco, Institute for Human Genetics, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811); University of California San Francisco, Bakar Computational Health Sciences Institute, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811); Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811); Bioinformatics Program, University of California San Francisco, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811)
6 New York Genome Center, New York, USA (GRID:grid.429884.b) (ISNI:0000 0004 1791 0895)
7 New York Genome Center, New York, USA (GRID:grid.429884.b) (ISNI:0000 0004 1791 0895); Center for Genomics and Systems Biology, New York University, New York, USA (GRID:grid.137628.9) (ISNI:0000 0004 1936 8753)
8 Bioinformatics Interdepartmental Program, University of California Los Angeles, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); David Geffen School of Medicine, University of California Los Angeles, Department of Pathology and Laboratory Medicine, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); David Geffen School of Medicine, University of California Los Angeles, Department of Computational Medicine, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
9 University of California Los Angeles, Department of Computer Science, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); David Geffen School of Medicine, University of California Los Angeles, Department of Computational Medicine, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); David Geffen School of Medicine, University of California Los Angeles, Department of Anesthesiology and Perioperative Medicine, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718); University of California, Institute of Precision Health, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)